Treatment of acute myeloid leukemia in the elderly.

Item

http://www.wikidata.org/entity/Q42743023

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Treatment of acute myeloid leukemia in the elderly.

@en

Treatment of acute myeloid leukemia in the elderly.

@nl

type

Item

label

Treatment of acute myeloid leukemia in the elderly.

@en

Treatment of acute myeloid leukemia in the elderly.

@nl

prefLabel

Treatment of acute myeloid leukemia in the elderly.

@en

Treatment of acute myeloid leukemia in the elderly.

@nl

P1476

Treatment of acute myeloid leukemia in the elderly.

@en

P2093

Elihu H Estey

http://www.w3.org/2001/XMLSchema#string

P2860

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study

Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.

Reduced-intensity conditioning transplantation in myeloid malignancies.

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial.

P304

795-798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3324/HAEMATOL.2011.044776

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51184135

http://www.w3.org/2001/XMLSchema#string

P698

21632842

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

3105638

http://www.w3.org/2001/XMLSchema#string